首页 > 最新文献

Mediators of Inflammation最新文献

英文 中文
Development and Evaluation of an Innovative Inflammatory Prognostic Score for Predicting Long-Term Mortality in Patients With Pulmonary Embolism. 用于预测肺栓塞患者长期死亡率的创新炎症预后评分的开发和评估。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/mi/6325915
Ning Zhu, Lei Zhang, Jiabao Wu, Fei Ye, Nanding Yu, Chao Cao, Limin Chen
<p><strong>Background: </strong>Systemic inflammation is closely associated with adverse outcomes in pulmonary embolism (PE). This study aimed to develop and evaluate a novel inflammatory prognostic score (IPS) derived from multiple inflammation-related biomarkers to predict long-term all-cause mortality in patients with acute PE.</p><p><strong>Methods: </strong>This retrospective cohort study included 1642 patients with confirmed acute PE admitted between January 2016 and January 2024 at the First Affiliated Hospital of Ningbo University and the Affiliated People Hospital of Ningbo University. The primary outcome was all-cause mortality. Follow-up was conducted in January 2025. Fifteen inflammatory biomarkers were analyzed, including C-reactive protein (CRP), white blood cell count (WBC), neutrophil count (NEU), lymphocyte count (LYM), monocyte count (MON), red cell distribution width (RDW), platelet count (PLT), and eight derived indices: neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-MLR (NMLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and inflammatory burden index (IBI). IPS was constructed using least absolute shrinkage and selection operator (LASSO) Cox regression. Prognostic performance was assessed using Kaplan-Meier survival analysis, multivariable Cox regression, time-dependent receiver operating characteristic (ROC) analysis, and random survival forest (RSF).</p><p><strong>Results: </strong>During a median follow-up of 43.87 months, 262 patients (16.0%) died. The IPS was calculated as: IPS = 0.395 × IBI + 0.236 × RDW + 0.208 × SIRI + 0.115 × MLR + 0.040 × CRP. Patients with high IPS (≥0.55) had a significantly higher risk of all-cause mortality compared to those with low IPS (adjusted hazard ratio [HR] = 2.55, 95% confidence intervals [CI]: 1.92-3.38; <i>p</i> < 0.001). Time-dependent area under the curve (AUC) for IPS were 0.756, 0.768, and 0.773 at 1, 3, and 5 years, respectively. When added to the baseline clinical model-including age, length of hospital stay, deep vein thrombosis, diastolic blood pressure, body mass index (BMI), lactate, log-transformed serum creatinine, blood urea nitrogen (BUN), log-transformed D-dimer, left ventricular ejection fraction (LVEF), pulmonary artery systolic pressure (PASP), and computed tomography pulmonary angiography (CTPA)-based embolism location (main pulmonary artery)-IPS improved the AUC from 0.820 to 0.886 at 3 years (<i>p</i> < 0.001, DeLong test). RSF analysis further identified IPS as the most informative inflammatory predictor of mortality.</p><p><strong>Conclusions: </strong>The IPS, derived from five routinely available inflammatory biomarkers, was independently associated with long-term mortality and significantly enhanced risk stratification beyond traditional clinical predictors in patients with acute PE. This score may support early prognostic a
背景:全身性炎症与肺栓塞(PE)的不良结局密切相关。本研究旨在开发和评估一种基于多种炎症相关生物标志物的新型炎症预后评分(IPS),以预测急性PE患者的长期全因死亡率。方法:本回顾性队列研究纳入2016年1月至2024年1月在宁波大学第一附属医院和宁波大学附属人民医院住院的确诊急性PE患者1642例。主要结局为全因死亡率。随访于2025年1月进行。分析了15种炎症生物标志物,包括c反应蛋白(CRP)、白细胞计数(WBC)、中性粒细胞计数(NEU)、淋巴细胞计数(LYM)、单核细胞计数(MON)、红细胞分布宽度(RDW)、血小板计数(PLT)和8个衍生指标:中性粒细胞与淋巴细胞比值(NLR)、衍生性NLR (dNLR)、单核细胞与淋巴细胞比值(MLR)、中性粒细胞-MLR (NMLR)、血小板与淋巴细胞比值(PLR)、全身免疫-炎症指数(SII)、全身炎症反应指数(SIRI)和炎症负担指数(IBI)。IPS采用最小绝对收缩和选择算子(LASSO) Cox回归构建。采用Kaplan-Meier生存分析、多变量Cox回归、随时间变化的受试者工作特征(ROC)分析和随机生存森林(RSF)评估预后。结果:中位随访43.87个月,262例(16.0%)患者死亡。IPS被计算为:IPS = 0.395×IBI + 0.236×RDW + 0.208×SIRI + 0.115×高钙+ 0.040×c反应蛋白。高IPS患者(≥0.55)的全因死亡率明显高于低IPS患者(校正风险比[HR] = 2.55, 95%可信区间[CI]: 1.92-3.38; p < 0.001)。在1年、3年和5年,IPS的曲线下面积(AUC)随时间变化分别为0.756、0.768和0.773。当加入基线临床模型(包括年龄、住院时间、深静脉血栓形成、舒张压、体重指数(BMI)、乳酸、对数转化血清肌酐、血尿素氮(BUN)、对数转化d -二聚体、左室射血分数(LVEF)、肺动脉收缩压(PASP)和基于肺血管造影(CTPA)的栓塞位置(肺动脉主动脉))时,ips将3年AUC从0.820提高到0.886 (p < 0.001)。德龙测试)。RSF分析进一步确定IPS是死亡率最具信息性的炎症预测因子。结论:来自5种常规炎症生物标志物的IPS与急性PE患者的长期死亡率独立相关,并显著增强了传统临床预测因子的风险分层。该评分可支持早期预后评估和个体化治疗。
{"title":"Development and Evaluation of an Innovative Inflammatory Prognostic Score for Predicting Long-Term Mortality in Patients With Pulmonary Embolism.","authors":"Ning Zhu, Lei Zhang, Jiabao Wu, Fei Ye, Nanding Yu, Chao Cao, Limin Chen","doi":"10.1155/mi/6325915","DOIUrl":"10.1155/mi/6325915","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Systemic inflammation is closely associated with adverse outcomes in pulmonary embolism (PE). This study aimed to develop and evaluate a novel inflammatory prognostic score (IPS) derived from multiple inflammation-related biomarkers to predict long-term all-cause mortality in patients with acute PE.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective cohort study included 1642 patients with confirmed acute PE admitted between January 2016 and January 2024 at the First Affiliated Hospital of Ningbo University and the Affiliated People Hospital of Ningbo University. The primary outcome was all-cause mortality. Follow-up was conducted in January 2025. Fifteen inflammatory biomarkers were analyzed, including C-reactive protein (CRP), white blood cell count (WBC), neutrophil count (NEU), lymphocyte count (LYM), monocyte count (MON), red cell distribution width (RDW), platelet count (PLT), and eight derived indices: neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-MLR (NMLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and inflammatory burden index (IBI). IPS was constructed using least absolute shrinkage and selection operator (LASSO) Cox regression. Prognostic performance was assessed using Kaplan-Meier survival analysis, multivariable Cox regression, time-dependent receiver operating characteristic (ROC) analysis, and random survival forest (RSF).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During a median follow-up of 43.87 months, 262 patients (16.0%) died. The IPS was calculated as: IPS = 0.395 × IBI + 0.236 × RDW + 0.208 × SIRI + 0.115 × MLR + 0.040 × CRP. Patients with high IPS (≥0.55) had a significantly higher risk of all-cause mortality compared to those with low IPS (adjusted hazard ratio [HR] = 2.55, 95% confidence intervals [CI]: 1.92-3.38; &lt;i&gt;p&lt;/i&gt; &lt; 0.001). Time-dependent area under the curve (AUC) for IPS were 0.756, 0.768, and 0.773 at 1, 3, and 5 years, respectively. When added to the baseline clinical model-including age, length of hospital stay, deep vein thrombosis, diastolic blood pressure, body mass index (BMI), lactate, log-transformed serum creatinine, blood urea nitrogen (BUN), log-transformed D-dimer, left ventricular ejection fraction (LVEF), pulmonary artery systolic pressure (PASP), and computed tomography pulmonary angiography (CTPA)-based embolism location (main pulmonary artery)-IPS improved the AUC from 0.820 to 0.886 at 3 years (&lt;i&gt;p&lt;/i&gt; &lt; 0.001, DeLong test). RSF analysis further identified IPS as the most informative inflammatory predictor of mortality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The IPS, derived from five routinely available inflammatory biomarkers, was independently associated with long-term mortality and significantly enhanced risk stratification beyond traditional clinical predictors in patients with acute PE. This score may support early prognostic a","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"6325915"},"PeriodicalIF":4.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
lncRNA NKILA Promotes Warburg Effect and Immune Escape in Intrahepatic Cholangiocarcinoma by Regulating the MTX1/TOMM40 Axis. lncRNA NKILA通过调节MTX1/TOMM40轴促进肝内胆管癌的Warburg效应和免疫逃逸。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/mi/7712817
Meiying Zhu, Hui Zhu, Zunqiang Zhou, Haiming Zheng, Zhixia Dong, Wenhong Dong, Xinjian Wan

Background and aims: Intrahepatic cholangiocarcinoma (ICC) is an aggressive malignancy with high heterogeneity and poor prognosis. Long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis through dysregulated expression. We explored the effects and mechanisms of nuclear transcription factor NF-κB interacting lncRNA (NKILA) in ICC.

Methods: Bioinformatic analysis was performed to determine the expression and relationship of NKILA with metaxin 1 (MTX1), and translocase of outer mitochondrial membrane 40 (TOMM40) expression in ICC tissue samples. Cholangiocarcinoma cell lines were cultured in vitro and the transplanted tumor model was constructed in vivo to study the role of NKILA in ICC. Immunohistochemistry (IHC), Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR) were used to detect the effects of NKILA on the Warburg effect, autophagy, programed cell death 1 ligand 1 (PD-L1) expression, and CD8+ T cytotoxicity in ICC cells. RNA immunoprecipitation (IP) (RIP) assay and RNA-RNA pull down assays were utilized to detect the binding of NKILA and MTX1, and CO-IP was performed to assess the interaction between MTX1 and TOMM40.

Results: We found that NKILA, MTX1, and TOMM40 were substantially upregulated in ICC tissues, and NKILA silencing reduced MTX1-TOMM40 binding in ICC cells. NKILA facilitated proliferation, invasion, Warburg effects, and autophagy of ICC cells by regulating mammalian target of rapamycin (mTOR) pathway, PD-L1 expression, and CD8+ T cytotoxicity, while dichloroacetate (DCA) could reverse these effects. Mechanistically, NKILA binds directly to MTX1 mRNA, which stabilizes MTX1 mRNA and thereby promotes the expression of MTX1 protein. NKILA silencing could inactivate MTX1/TOMM40 axis to inhibit Warburg effect and autophagy-associated immune escape.

Conclusions: LncRNA NKILA promotes Warburg effect and immune escape in ICC by regulating the MTX1/TOMM40 axis.

背景和目的:肝内胆管癌(ICC)是一种侵袭性恶性肿瘤,异质性高,预后差。长链非编码rna (lncRNAs)通过表达失调在肿瘤发生中发挥关键作用。探讨核转录因子NF-κB与lncRNA (NKILA)在ICC中的作用及其机制。方法:采用生物信息学方法检测NKILA在ICC组织样品中metaxin 1 (MTX1)和线粒体外膜转位酶40 (TOMM40)的表达及其与MTX1和MTX1的关系。通过体外培养胆管癌细胞系和体内构建移植瘤模型,研究NKILA在ICC中的作用。采用免疫组织化学(IHC)、Western blot和定量实时聚合酶链反应(qRT-PCR)检测NKILA对ICC细胞Warburg效应、自噬、程序性细胞死亡1配体1 (PD-L1)表达和CD8+ T细胞毒性的影响。采用RNA免疫沉淀(RIP)法和RNA-RNA拉下法检测NKILA与MTX1的结合,采用CO-IP法评估MTX1与TOMM40的相互作用。结果:我们发现NKILA、MTX1和TOMM40在ICC组织中显著上调,NKILA沉默减少了ICC细胞中MTX1-TOMM40的结合。NKILA通过调节哺乳动物雷帕霉素靶蛋白(mTOR)通路、PD-L1表达和CD8+ T细胞毒性,促进ICC细胞的增殖、侵袭、Warburg效应和自噬,而二氯乙酸(DCA)可以逆转这些作用。在机制上,NKILA直接与MTX1 mRNA结合,稳定MTX1 mRNA,从而促进MTX1蛋白的表达。NKILA沉默可使MTX1/TOMM40轴失活,抑制Warburg效应和自噬相关的免疫逃逸。结论:LncRNA NKILA通过调节MTX1/TOMM40轴促进ICC的Warburg效应和免疫逃逸。
{"title":"lncRNA NKILA Promotes Warburg Effect and Immune Escape in Intrahepatic Cholangiocarcinoma by Regulating the MTX1/TOMM40 Axis.","authors":"Meiying Zhu, Hui Zhu, Zunqiang Zhou, Haiming Zheng, Zhixia Dong, Wenhong Dong, Xinjian Wan","doi":"10.1155/mi/7712817","DOIUrl":"10.1155/mi/7712817","url":null,"abstract":"<p><strong>Background and aims: </strong>Intrahepatic cholangiocarcinoma (ICC) is an aggressive malignancy with high heterogeneity and poor prognosis. Long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis through dysregulated expression. We explored the effects and mechanisms of nuclear transcription factor NF-κB interacting lncRNA (NKILA) in ICC.</p><p><strong>Methods: </strong>Bioinformatic analysis was performed to determine the expression and relationship of NKILA with metaxin 1 (MTX1), and translocase of outer mitochondrial membrane 40 (TOMM40) expression in ICC tissue samples. Cholangiocarcinoma cell lines were cultured in vitro and the transplanted tumor model was constructed in vivo to study the role of NKILA in ICC. Immunohistochemistry (IHC), Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR) were used to detect the effects of NKILA on the Warburg effect, autophagy, programed cell death 1 ligand 1 (PD-L1) expression, and CD8<sup>+</sup> T cytotoxicity in ICC cells. RNA immunoprecipitation (IP) (RIP) assay and RNA-RNA pull down assays were utilized to detect the binding of NKILA and MTX1, and CO-IP was performed to assess the interaction between MTX1 and TOMM40.</p><p><strong>Results: </strong>We found that NKILA, MTX1, and TOMM40 were substantially upregulated in ICC tissues, and NKILA silencing reduced MTX1-TOMM40 binding in ICC cells. NKILA facilitated proliferation, invasion, Warburg effects, and autophagy of ICC cells by regulating mammalian target of rapamycin (mTOR) pathway, PD-L1 expression, and CD8<sup>+</sup> T cytotoxicity, while dichloroacetate (DCA) could reverse these effects. Mechanistically, NKILA binds directly to MTX1 mRNA, which stabilizes MTX1 mRNA and thereby promotes the expression of MTX1 protein. NKILA silencing could inactivate MTX1/TOMM40 axis to inhibit Warburg effect and autophagy-associated immune escape.</p><p><strong>Conclusions: </strong>LncRNA NKILA promotes Warburg effect and immune escape in ICC by regulating the MTX1/TOMM40 axis.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"7712817"},"PeriodicalIF":4.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Cell Transcriptomic Analysis Reveals an Inflammatory Antigen-Presenting Macrophages Subtype Drive Vitiligo Pathogenesis Through STAT1-Mediated Dual Mechanisms. 单细胞转录组学分析揭示炎症抗原呈递巨噬细胞亚型通过stat1介导的双重机制驱动白癜风发病。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/mi/8878698
Ruozhou Qi, Min Huang, Ziyi Lin, Huanhuan Deng, Rule Sa, Yi Chen, Guangshan Chen, Xingwu Duan, Liu Jinhui

Background: Vitiligo is a common depigmentary disorder characterized by progressive melanocyte (MEL) loss. While T-cell activation is central to its pathogenesis, the role of macrophages remains poorly understood. This study characterizes macrophage heterogeneity and function in vitiligo using single-cell transcriptomic analysis and experimental validation.

Methods: We analyzed single-cell RNA sequencing (scRNA-seq) data from healthy and vitiligo-affected skin to identify macrophage subpopulations. Computational analyses included cell subpopulation clustering, pseudotime trajectory inference, cell-cell communication, and high-dimensional weighted gene coexpression network analysis (hdWGCNA). In vivo and in vitro experiments examined the effects of STAT1 suppression on the macrophage inflammatory phenotype and antigen presentation capacity.

Results: scRNA-seq analysis identified macrophages and T cell subsets enriched in vitiligo. Macrophage subclustering identified five subpopulations, with inflammatory antigen-presenting macrophages (Mac-InflamAP) significantly enriched in vitiligo lesions and M1-polarized. Pseudotime analysis revealed Mac-InflamAP as a terminal differentiation state. Cell-cell communication analysis showed Mac-InflamAP exerts TNF-mediated inhibitory effects on MELs while enhancing T-cell antigen presentation, thereby promoting MEL loss. hdWGCNA identified STAT1 as a key regulator highly expressed in Mac-InflamAP. In vivo, STAT1 inhibition by fludarabine ameliorated vitiligo progression by suppressing T cell activation and macrophage M1-polarization. In vitro experiments confirmed STAT1 suppression reduced macrophage M1 polarization, inflammatory phenotype, and antigen presentation capabilities.

Conclusions: This study reveals an uncharacterized inflammatory macrophage subpopulation crucial to vitiligo pathogenesis through dual mechanisms: direct MEL inhibition and enhanced T-cell activation. The identification of STAT1 as a key regulatory molecule provides a novel therapeutic target for vitiligo. These findings advance our understanding of immune-mediated mechanisms in vitiligo.

背景:白癜风是一种常见的以进行性黑色素细胞(MEL)丢失为特征的色素沉着疾病。虽然t细胞活化是其发病机制的核心,但巨噬细胞的作用仍然知之甚少。本研究利用单细胞转录组学分析和实验验证来表征巨噬细胞在白癜风中的异质性和功能。方法:我们分析了来自健康皮肤和白癜风皮肤的单细胞RNA测序(scRNA-seq)数据,以鉴定巨噬细胞亚群。计算分析包括细胞亚群聚类、伪时间轨迹推断、细胞间通讯和高维加权基因共表达网络分析(hdWGCNA)。体内和体外实验检测了STAT1抑制对巨噬细胞炎症表型和抗原递呈能力的影响。结果:scRNA-seq分析鉴定出白癜风中富集的巨噬细胞和T细胞亚群。巨噬细胞亚群鉴定出5个亚群,炎症抗原呈递巨噬细胞(Mac-InflamAP)在白癜风病变和m1极化中显著富集。伪时间分析显示Mac-InflamAP为终末分化状态。细胞间通讯分析显示,Mac-InflamAP对MEL发挥tnf介导的抑制作用,同时增强t细胞抗原呈递,从而促进MEL丢失。hdWGCNA发现STAT1是Mac-InflamAP中高度表达的关键调控因子。在体内,氟达拉滨抑制STAT1通过抑制T细胞活化和巨噬细胞m1极化改善白癜风的进展。体外实验证实STAT1抑制可降低巨噬细胞M1极化、炎症表型和抗原递呈能力。结论:本研究揭示了一种非特征性的炎性巨噬细胞亚群通过双重机制对白癜风发病至关重要:直接MEL抑制和增强t细胞活化。STAT1作为关键调控分子的鉴定为白癜风的治疗提供了新的靶点。这些发现促进了我们对白癜风免疫介导机制的理解。
{"title":"Single-Cell Transcriptomic Analysis Reveals an Inflammatory Antigen-Presenting Macrophages Subtype Drive Vitiligo Pathogenesis Through STAT1-Mediated Dual Mechanisms.","authors":"Ruozhou Qi, Min Huang, Ziyi Lin, Huanhuan Deng, Rule Sa, Yi Chen, Guangshan Chen, Xingwu Duan, Liu Jinhui","doi":"10.1155/mi/8878698","DOIUrl":"10.1155/mi/8878698","url":null,"abstract":"<p><strong>Background: </strong>Vitiligo is a common depigmentary disorder characterized by progressive melanocyte (MEL) loss. While T-cell activation is central to its pathogenesis, the role of macrophages remains poorly understood. This study characterizes macrophage heterogeneity and function in vitiligo using single-cell transcriptomic analysis and experimental validation.</p><p><strong>Methods: </strong>We analyzed single-cell RNA sequencing (scRNA-seq) data from healthy and vitiligo-affected skin to identify macrophage subpopulations. Computational analyses included cell subpopulation clustering, pseudotime trajectory inference, cell-cell communication, and high-dimensional weighted gene coexpression network analysis (hdWGCNA). In vivo and in vitro experiments examined the effects of STAT1 suppression on the macrophage inflammatory phenotype and antigen presentation capacity.</p><p><strong>Results: </strong>scRNA-seq analysis identified macrophages and T cell subsets enriched in vitiligo. Macrophage subclustering identified five subpopulations, with inflammatory antigen-presenting macrophages (Mac-InflamAP) significantly enriched in vitiligo lesions and M1-polarized. Pseudotime analysis revealed Mac-InflamAP as a terminal differentiation state. Cell-cell communication analysis showed Mac-InflamAP exerts TNF-mediated inhibitory effects on MELs while enhancing T-cell antigen presentation, thereby promoting MEL loss. hdWGCNA identified STAT1 as a key regulator highly expressed in Mac-InflamAP. In vivo, STAT1 inhibition by fludarabine ameliorated vitiligo progression by suppressing T cell activation and macrophage M1-polarization. In vitro experiments confirmed STAT1 suppression reduced macrophage M1 polarization, inflammatory phenotype, and antigen presentation capabilities.</p><p><strong>Conclusions: </strong>This study reveals an uncharacterized inflammatory macrophage subpopulation crucial to vitiligo pathogenesis through dual mechanisms: direct MEL inhibition and enhanced T-cell activation. The identification of STAT1 as a key regulatory molecule provides a novel therapeutic target for vitiligo. These findings advance our understanding of immune-mediated mechanisms in vitiligo.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"8878698"},"PeriodicalIF":4.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Single-Cell Characterization of LDL in the Ovarian Cancer Microenvironment and Its Prognostic Implications. 卵巢癌微环境中LDL的综合单细胞特征及其预后意义。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-22 eCollection Date: 2025-01-01 DOI: 10.1155/mi/6540537
Kang Tian, Jingjie Liu, Lei Zhou, Yue Gao, Shuzhen Wei, Liu Jinhui

Background: Low-density lipoprotein (LDL) is a critical regulator of lipid metabolism and has been implicated in the development and progression of various malignancies. However, its specific roles and mechanisms in the ovarian cancer tumor microenvironment (TME) remain unclear. This study aimed to comprehensively elucidate the distribution, functional pathways, and prognostic value of LDL in ovarian cancer using single-cell transcriptome analysis.

Methods: Single-cell transcriptome data from ovarian cancer patients were analyzed. The AUCell algorithm was used to score LDL-related gene expression in different cell subsets, dividing cells into high and low LDL score groups. Functional pathway enrichment (Gene Set Variation Analysis [GSVA]) and cell-cell communication (CellChat) analyses were performed. Differentially expressed genes (DEGs) identified between the two groups were combined with bulk RNA-seq data from eight cohorts to construct the LDL-related ovarian cancer prognostic signature (LDLOCPS) using machine learning. Prognostic performance and immune landscape differences were evaluated between high and low LDLOCPS groups.

Results: LDL was predominantly highly expressed in myeloid cells (macrophages and monocytes) and stromal cells (fibroblasts, smooth muscle cells, and endothelial cells) within the ovarian cancer TME. GSVA revealed that the high LDL score group was significantly enriched for pathways including epithelial-mesenchymal transition (EMT), inflammatory response, coagulation, and angiogenesis. CellChat analysis demonstrated enhanced cell-cell communication involving IL6, CSF, and tenascin in the high LDL score group, with SPP1+ macrophages and monocytes showing stronger incoming and outgoing signals. The LDLOCPS model, constructed from bulk transcriptomic data and validated across eight cohorts, effectively stratified patients by risk; the high LDLOCPS group exhibited significantly worse overall survival. Receiver operating characteristic (ROC) and principal component analysis (PCA) analyses confirmed the robust predictive performance of LDLOCPS. Moreover, patients in the high LDLOCPS group showed reduced immune cell infiltration and lower expression of immune-related genes, suggesting an immunosuppressive microenvironment.

Conclusion: This study systematically reveals the spatial distribution of LDL within the ovarian cancer microenvironment and uncovers its regulatory roles in tumor progression through multiple signaling pathways. The LDLOCPS model provides a valuable tool for risk stratification and prognosis prediction in ovarian cancer. LDL-mediated microenvironmental and immunosuppressive effects may offer novel insights for developing targeted and immunomodulatory therapies in ovarian cancer.

背景:低密度脂蛋白(LDL)是脂质代谢的关键调节因子,与各种恶性肿瘤的发生和进展有关。然而,其在卵巢癌肿瘤微环境(TME)中的具体作用和机制尚不清楚。本研究旨在通过单细胞转录组分析全面阐明LDL在卵巢癌中的分布、功能途径和预后价值。方法:对卵巢癌患者单细胞转录组数据进行分析。采用AUCell算法对不同细胞亚群中的LDL相关基因表达进行评分,将细胞分为高LDL评分组和低LDL评分组。功能途径富集(基因集变异分析[GSVA])和细胞-细胞通讯(CellChat)分析。两组之间鉴定的差异表达基因(DEGs)与来自8个队列的大量RNA-seq数据相结合,使用机器学习构建ldl相关卵巢癌预后特征(LDLOCPS)。评估高、低LDLOCPS组的预后表现和免疫景观差异。结果:低密度脂蛋白主要在卵巢癌TME内的骨髓细胞(巨噬细胞和单核细胞)和基质细胞(成纤维细胞、平滑肌细胞和内皮细胞)中高表达。GSVA显示,高LDL评分组的上皮-间质转化(EMT)、炎症反应、凝血和血管生成等途径显著丰富。CellChat分析显示,在高LDL评分组,涉及IL6、CSF和tenascin的细胞间通讯增强,SPP1+巨噬细胞和单核细胞显示更强的输入和输出信号。LDLOCPS模型由大量转录组学数据构建,并在8个队列中得到验证,有效地按风险对患者进行分层;高LDLOCPS组的总生存率明显较差。受试者工作特征(ROC)和主成分分析(PCA)分析证实了LDLOCPS的稳健预测性能。此外,高LDLOCPS组患者免疫细胞浸润减少,免疫相关基因表达降低,提示存在免疫抑制微环境。结论:本研究系统揭示了低密度脂蛋白在卵巢癌微环境中的空间分布,并通过多种信号通路揭示了其在肿瘤进展中的调控作用。LDLOCPS模型为卵巢癌的风险分层和预后预测提供了有价值的工具。低密度脂蛋白介导的微环境和免疫抑制效应可能为开发卵巢癌靶向和免疫调节疗法提供新的见解。
{"title":"Comprehensive Single-Cell Characterization of LDL in the Ovarian Cancer Microenvironment and Its Prognostic Implications.","authors":"Kang Tian, Jingjie Liu, Lei Zhou, Yue Gao, Shuzhen Wei, Liu Jinhui","doi":"10.1155/mi/6540537","DOIUrl":"10.1155/mi/6540537","url":null,"abstract":"<p><strong>Background: </strong>Low-density lipoprotein (LDL) is a critical regulator of lipid metabolism and has been implicated in the development and progression of various malignancies. However, its specific roles and mechanisms in the ovarian cancer tumor microenvironment (TME) remain unclear. This study aimed to comprehensively elucidate the distribution, functional pathways, and prognostic value of LDL in ovarian cancer using single-cell transcriptome analysis.</p><p><strong>Methods: </strong>Single-cell transcriptome data from ovarian cancer patients were analyzed. The AUCell algorithm was used to score LDL-related gene expression in different cell subsets, dividing cells into high and low LDL score groups. Functional pathway enrichment (Gene Set Variation Analysis [GSVA]) and cell-cell communication (CellChat) analyses were performed. Differentially expressed genes (DEGs) identified between the two groups were combined with bulk RNA-seq data from eight cohorts to construct the LDL-related ovarian cancer prognostic signature (LDLOCPS) using machine learning. Prognostic performance and immune landscape differences were evaluated between high and low LDLOCPS groups.</p><p><strong>Results: </strong>LDL was predominantly highly expressed in myeloid cells (macrophages and monocytes) and stromal cells (fibroblasts, smooth muscle cells, and endothelial cells) within the ovarian cancer TME. GSVA revealed that the high LDL score group was significantly enriched for pathways including epithelial-mesenchymal transition (EMT), inflammatory response, coagulation, and angiogenesis. CellChat analysis demonstrated enhanced cell-cell communication involving IL6, CSF, and tenascin in the high LDL score group, with SPP1+ macrophages and monocytes showing stronger incoming and outgoing signals. The LDLOCPS model, constructed from bulk transcriptomic data and validated across eight cohorts, effectively stratified patients by risk; the high LDLOCPS group exhibited significantly worse overall survival. Receiver operating characteristic (ROC) and principal component analysis (PCA) analyses confirmed the robust predictive performance of LDLOCPS. Moreover, patients in the high LDLOCPS group showed reduced immune cell infiltration and lower expression of immune-related genes, suggesting an immunosuppressive microenvironment.</p><p><strong>Conclusion: </strong>This study systematically reveals the spatial distribution of LDL within the ovarian cancer microenvironment and uncovers its regulatory roles in tumor progression through multiple signaling pathways. The LDLOCPS model provides a valuable tool for risk stratification and prognosis prediction in ovarian cancer. LDL-mediated microenvironmental and immunosuppressive effects may offer novel insights for developing targeted and immunomodulatory therapies in ovarian cancer.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"6540537"},"PeriodicalIF":4.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunomodulatory Mechanisms of Rehmanniae Radix Praeparata-Achyranthes Root-Chinese Angelica Root Combination in Nontraumatic Osteonecrosis of the Femoral Head: A Comprehensive Network Pharmacology and Molecular Docking Study Focusing on Immunological Pathways. 地黄、牛膝、当归组合对非外伤性股骨头坏死的免疫调节机制:以免疫通路为重点的综合网络药理学和分子对接研究
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-20 eCollection Date: 2025-01-01 DOI: 10.1155/mi/2808908
Xin Li, Liqi Ng, Caiying Liu, Leilei Qin, Pengcheng Xiao, Chaozong Liu, Yusong Liu, Qiuping Zhang, Wei Huang, Yu Zhou, Wencai Liu
<p><strong>Objective: </strong>Nontraumatic osteonecrosis of the femoral head (NONFH) is a devastating condition characterised by immune dysregulation and sterile inflammation, which are increasingly acknowledged as central pathogenic mechanisms. This study aims to identify the core herbal combination for NONFH and systematically explore its immunomodulatory effects and underlying pharmacological mechanisms, with a focus on immune system interactions.</p><p><strong>Methods: </strong>The core combination 'Rehmanniae radix praeparata (SDH)-achyranthes root (NX)-Chinese angelica root (DG)' (SND) was identified via data mining of clinical literature using the Traditional Chinese Medicine Inheritance Support System (TCMISS) V2.5 platform. Its chemical constituents were characterised by ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS<sup>E</sup>) technology, yielding 127 identified compounds, 47 of which were selected as bioactive components based on drug-likeness screening. The potential molecular targets of SND and NONFH were predicted and intersected, with a focus on immune-related targets. Subsequent comprehensive enrichment analysis was performed, emphasising immune pathway involvement, along with immune infiltration profiling. A support vector machine (SVM) model was constructed to identify key immune-related targets, and interactions were validated via molecular docking and molecular dynamics (MD) simulations.</p><p><strong>Results: </strong>SND shared 46 candidate targets with NONFH. Enrichment analysis revealed these targets were significantly enriched in immune-inflammatory pathways, especially those related to immune cell activation and regulation. Notably, pathways involved in neutrophil extracellular trap (NET) formation and other innate immune responses were prominent. Machine learning identified five key targets: ACP1, NDUFAF3, haematopoietic cell kinase (HCK), CXCR2 and platelet-activating factor receptor (PTAFR)-all of which play critical roles in the modulation, signalling and activation of immune cells, particularly neutrophils and macrophages. Subsequent immune infiltration analysis demonstrated a strong correlation between these key targets (e.g. HCK, CXCR2 and PTAFR) and neutrophil abundance in NONFH. Molecular docking (MD) and molecular dynamics simulations (MDS). MD confirmed stable binding between the active components and these targets, with the HCK-chrysophanic acid complex exhibiting the strongest affinity (binding energy: -8.7 kcal/mol).</p><p><strong>Conclusion: </strong>Our integrated analysis suggests that SND alleviates NONFH primarily through multi-target immunomodulation, explicitly involving suppression of NET formation and regulation of immune cell activity, especially neutrophils and osteoclasts. This study presents a novel, immunologically explicit hypothesis for the mechanism of SND against NONFH, providing a solid theoretical foundation for future experimen
目的:非外伤性股骨头坏死(Nontraumatic osteonecrosis of femoral head, NONFH)是一种以免疫失调和无菌性炎症为特征的破坏性疾病,越来越多地认为这是主要的致病机制。本研究旨在确定非赤霉病的核心中药组合,系统探讨其免疫调节作用和潜在的药理学机制,重点研究免疫系统相互作用。方法:采用中药传承支持系统(TCMISS) V2.5平台对临床文献进行数据挖掘,确定核心组合“熟地黄(SDH)-牛膝根(NX)-当归根(SND)”。采用超高效液相色谱-四极杆飞行时间质谱(UHPLC-Q-TOF-MSE)技术对其化学成分进行了表征,共鉴定出127种化合物,其中47种化合物经药物相似性筛选为生物活性成分。对SND和NONFH的潜在分子靶点进行了预测和交叉,重点关注免疫相关靶点。随后进行了全面的富集分析,强调免疫通路的参与,以及免疫浸润谱。构建支持向量机(SVM)模型识别关键免疫相关靶点,并通过分子对接和分子动力学(MD)模拟验证相互作用。结果:SND与NONFH共有46个候选靶点。富集分析显示,这些靶点在免疫炎症通路中显著富集,特别是与免疫细胞激活和调节相关的靶点。值得注意的是,涉及中性粒细胞胞外陷阱(NET)形成和其他先天免疫反应的途径是突出的。机器学习确定了五个关键靶点:ACP1, NDUFAF3,造血细胞激酶(HCK), CXCR2和血小板活化因子受体(PTAFR)-所有这些靶点在免疫细胞,特别是中性粒细胞和巨噬细胞的调节,信号传导和激活中发挥关键作用。随后的免疫浸润分析表明,这些关键靶点(如HCK、CXCR2和PTAFR)与NONFH中中性粒细胞丰度之间存在很强的相关性。分子对接(MD)和分子动力学模拟(MDS)MD证实了活性成分与这些靶标之间的稳定结合,其中hck -大黄酸配合物的亲和力最强(结合能:-8.7 kcal/mol)。结论:我们的综合分析表明,SND主要通过多靶点免疫调节来缓解NONFH,明确涉及抑制NET形成和调节免疫细胞活性,特别是中性粒细胞和破骨细胞。本研究为SND抗NONFH的机制提出了一个新的、免疫学明确的假说,为今后的实验验证和临床应用提供了坚实的理论基础。
{"title":"Immunomodulatory Mechanisms of Rehmanniae Radix Praeparata-Achyranthes Root-Chinese Angelica Root Combination in Nontraumatic Osteonecrosis of the Femoral Head: A Comprehensive Network Pharmacology and Molecular Docking Study Focusing on Immunological Pathways.","authors":"Xin Li, Liqi Ng, Caiying Liu, Leilei Qin, Pengcheng Xiao, Chaozong Liu, Yusong Liu, Qiuping Zhang, Wei Huang, Yu Zhou, Wencai Liu","doi":"10.1155/mi/2808908","DOIUrl":"10.1155/mi/2808908","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Nontraumatic osteonecrosis of the femoral head (NONFH) is a devastating condition characterised by immune dysregulation and sterile inflammation, which are increasingly acknowledged as central pathogenic mechanisms. This study aims to identify the core herbal combination for NONFH and systematically explore its immunomodulatory effects and underlying pharmacological mechanisms, with a focus on immune system interactions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The core combination 'Rehmanniae radix praeparata (SDH)-achyranthes root (NX)-Chinese angelica root (DG)' (SND) was identified via data mining of clinical literature using the Traditional Chinese Medicine Inheritance Support System (TCMISS) V2.5 platform. Its chemical constituents were characterised by ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS&lt;sup&gt;E&lt;/sup&gt;) technology, yielding 127 identified compounds, 47 of which were selected as bioactive components based on drug-likeness screening. The potential molecular targets of SND and NONFH were predicted and intersected, with a focus on immune-related targets. Subsequent comprehensive enrichment analysis was performed, emphasising immune pathway involvement, along with immune infiltration profiling. A support vector machine (SVM) model was constructed to identify key immune-related targets, and interactions were validated via molecular docking and molecular dynamics (MD) simulations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;SND shared 46 candidate targets with NONFH. Enrichment analysis revealed these targets were significantly enriched in immune-inflammatory pathways, especially those related to immune cell activation and regulation. Notably, pathways involved in neutrophil extracellular trap (NET) formation and other innate immune responses were prominent. Machine learning identified five key targets: ACP1, NDUFAF3, haematopoietic cell kinase (HCK), CXCR2 and platelet-activating factor receptor (PTAFR)-all of which play critical roles in the modulation, signalling and activation of immune cells, particularly neutrophils and macrophages. Subsequent immune infiltration analysis demonstrated a strong correlation between these key targets (e.g. HCK, CXCR2 and PTAFR) and neutrophil abundance in NONFH. Molecular docking (MD) and molecular dynamics simulations (MDS). MD confirmed stable binding between the active components and these targets, with the HCK-chrysophanic acid complex exhibiting the strongest affinity (binding energy: -8.7 kcal/mol).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our integrated analysis suggests that SND alleviates NONFH primarily through multi-target immunomodulation, explicitly involving suppression of NET formation and regulation of immune cell activity, especially neutrophils and osteoclasts. This study presents a novel, immunologically explicit hypothesis for the mechanism of SND against NONFH, providing a solid theoretical foundation for future experimen","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"2808908"},"PeriodicalIF":4.2,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETRACTION: Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI via Its Anti-Inflammatory Effect. 回退:甘草酸抑制HMGB1通过其抗炎作用保护DAI脑损伤。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.1155/mi/9854643
Mediators Of Inflammation

[This retracts the article DOI: 10.1155/2016/4569521.].

[本文撤回文章DOI: 10.1155/2016/4569521.]。
{"title":"RETRACTION: Inhibiting HMGB1 with Glycyrrhizic Acid Protects Brain Injury after DAI via Its Anti-Inflammatory Effect.","authors":"Mediators Of Inflammation","doi":"10.1155/mi/9854643","DOIUrl":"10.1155/mi/9854643","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2016/4569521.].</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"9854643"},"PeriodicalIF":4.2,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETRACTION: Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation. 摘要:白细胞介素-10修饰的脂肪源性间充质干细胞通过调节成纤维细胞和炎症的生物学特性来预防增生性疤痕的形成。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/mi/9785923
Mediators Of Inflammation

[This retracts the article DOI: 10.1155/2022/6368311.].

[本文撤回文章DOI: 10.1155/2022/6368311.]。
{"title":"RETRACTION: Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation.","authors":"Mediators Of Inflammation","doi":"10.1155/mi/9785923","DOIUrl":"10.1155/mi/9785923","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/6368311.].</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"9785923"},"PeriodicalIF":4.2,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma". 更正“头颈部鳞状细胞癌7个免疫相关基因的预后价值及与治疗结果的相关性”。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/mi/9801859

[This corrects the article DOI: 10.1155/2023/8533476.].

[这更正了文章DOI: 10.1155/2023/8533476]。
{"title":"Correction to \"Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma\".","authors":"","doi":"10.1155/mi/9801859","DOIUrl":"10.1155/mi/9801859","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2023/8533476.].</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"9801859"},"PeriodicalIF":4.2,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma. 透明细胞肾细胞癌中efferocycytes介导的免疫调节的整合基因组学和单细胞见解。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1155/mi/8710699
Bing Shi, Minghao Deng, Jiakang Ma, Chao Chen, Aijin Peng, Anli Zhu, Rongchao Yang, Zhenhua Jin, Jian Zhu, Mingcong Zhang, Shuijie Shen, Liu Jinhui

Background: Efferocytosis, the phagocytic clearance of apoptotic cells, plays a key role in tumor progression and immune regulation, but its prognostic significance and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain unclear.

Methods: Four efferocytosis-related pathways were curated, and the pathway activities were quantified in ccRCC. Prognostic genes were identified by univariate Cox regression and used to construct linear survival models with multiple algorithms, with the optimal model selected by cross-validation. Associations between the risk score and tumor mutational burden (TMB), mutation profiles, and copy number variation (CNV) were subsequently evaluated. Multiomics integration highlighted RAC1 as a key risk gene, which was further examined using single-cell and spatial transcriptomics (ST) to characterize expression patterns, tumor microenvironment interactions, and pathway enrichments. Protein-level validation was performed using immunohistochemistry (IHC) data from the Human Protein Atlas.

Results: Efferocytosis pathway activity was upregulated in ccRCC, increased with disease stage, and correlated with poorer survival. The ridge regression-based prognostic model demonstrated consistent predictive performance across independent datasets and was associated with higher TMB, specific mutation patterns, and increased CNV. Notably, RAC1, identified as the top weighted gene in the model, was overexpressed in association with copy number amplification, showing preferential enrichment in malignant core regions and strong links to oncogenic signaling.

Conclusion: Efferocytosis activation characterizes aggressive ccRCC. The developed prognostic model and identification of RAC1 as a central effector link efferocytosis-related risk to immune remodeling and oncogenic signaling, providing potential biomarkers and therapeutic targets.

背景:Efferocytosis是对凋亡细胞的吞噬清除,在肿瘤进展和免疫调节中起关键作用,但其在透明细胞肾细胞癌(ccRCC)中的预后意义和分子机制尚不清楚。方法:筛选4条与efferocysis相关的通路,定量测定其在ccRCC中的活性。采用单变量Cox回归识别预后基因,并采用多种算法构建线性生存模型,通过交叉验证选择最优模型。随后评估了风险评分与肿瘤突变负担(TMB)、突变谱和拷贝数变异(CNV)之间的关系。多组学整合强调了RAC1是一个关键的风险基因,进一步使用单细胞和空间转录组学(ST)来表征表达模式、肿瘤微环境相互作用和途径富集。蛋白水平验证使用免疫组织化学(IHC)数据从人蛋白图谱。结果:在ccRCC中,Efferocytosis通路活性上调,随疾病分期升高,并与较差的生存率相关。基于脊回归的预后模型在独立数据集上表现出一致的预测性能,并与较高的TMB、特定突变模式和增加的CNV相关。值得注意的是,模型中权重最高的基因RAC1与拷贝数扩增相关过表达,在恶性核心区域优先富集,与致癌信号传导密切相关。结论:侵袭性ccRCC具有efferocytoactivation特征。发展的预后模型和RAC1作为中心效应物的鉴定将efferocysyis相关风险与免疫重塑和致癌信号联系起来,提供了潜在的生物标志物和治疗靶点。
{"title":"Integrative Genomic and Single-Cell Insights Into Efferocytosis-Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma.","authors":"Bing Shi, Minghao Deng, Jiakang Ma, Chao Chen, Aijin Peng, Anli Zhu, Rongchao Yang, Zhenhua Jin, Jian Zhu, Mingcong Zhang, Shuijie Shen, Liu Jinhui","doi":"10.1155/mi/8710699","DOIUrl":"10.1155/mi/8710699","url":null,"abstract":"<p><strong>Background: </strong>Efferocytosis, the phagocytic clearance of apoptotic cells, plays a key role in tumor progression and immune regulation, but its prognostic significance and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain unclear.</p><p><strong>Methods: </strong>Four efferocytosis-related pathways were curated, and the pathway activities were quantified in ccRCC. Prognostic genes were identified by univariate Cox regression and used to construct linear survival models with multiple algorithms, with the optimal model selected by cross-validation. Associations between the risk score and tumor mutational burden (TMB), mutation profiles, and copy number variation (CNV) were subsequently evaluated. Multiomics integration highlighted RAC1 as a key risk gene, which was further examined using single-cell and spatial transcriptomics (ST) to characterize expression patterns, tumor microenvironment interactions, and pathway enrichments. Protein-level validation was performed using immunohistochemistry (IHC) data from the Human Protein Atlas.</p><p><strong>Results: </strong>Efferocytosis pathway activity was upregulated in ccRCC, increased with disease stage, and correlated with poorer survival. The ridge regression-based prognostic model demonstrated consistent predictive performance across independent datasets and was associated with higher TMB, specific mutation patterns, and increased CNV. Notably, RAC1, identified as the top weighted gene in the model, was overexpressed in association with copy number amplification, showing preferential enrichment in malignant core regions and strong links to oncogenic signaling.</p><p><strong>Conclusion: </strong>Efferocytosis activation characterizes aggressive ccRCC. The developed prognostic model and identification of RAC1 as a central effector link efferocytosis-related risk to immune remodeling and oncogenic signaling, providing potential biomarkers and therapeutic targets.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"8710699"},"PeriodicalIF":4.2,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut-Bone Axis Mediates Exercise Modality-Dependent Suppression of Inflammatory Osteoclastogenesis in Ovariectomy-Induced Bone Loss. 肠-骨轴介导卵巢切除术引起的骨质流失中炎性破骨细胞发生的运动模式依赖性抑制。
IF 4.2 3区 医学 Q2 CELL BIOLOGY Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.1155/mi/5715332
Yucheng Gao, Hao Wang, Liu Shi, Mumin Cao, Xiaoyu Liu, Yuanwei Zhang, Xiangxu Chen, Yijun Rong, Bowen Han, Panpan Lu, Guangchun Dai, Wenbin Fan, Yunfeng Rui, Yingjuan Li

Exercise is crucial for postmenopausal osteoporosis (PMOP) management, yet the comparative efficacy of different exercise modalities and the underlying mechanisms remain unclear. This study investigated the differential effects of distance-matched high-intensity interval training (HIIT) and moderate-intensity continuous exercise (MICE) on ovariectomy (OVX)-induced osteoporosis (OP) in mice. After 12 weeks of training, micro-CT analysis revealed that MICE, but not HIIT, significantly attenuated OVX-induced bone loss and microstructural deterioration. Crucially, only MICE suppressed osteoclastogenesis and reduced proinflammatory factors (interleukin [IL]-6, IL-1β, and tumor necrosis factor-alpha [TNF-α]) expression in the femur, serum, and colon. Mechanistically, MICE uniquely restored gut microbiota (GM) diversity, mitigated dysbiosis, and enhanced intestinal barrier integrity by upregulating the expression of tight junction proteins (TJPs; ZO-1, occludin, and claudin-1), thereby reducing systemic inflammation. In contrast, HIIT failed to ameliorate GM imbalance and intestinal permeability. Our findings demonstrate that the protective effect of MICE on OVX-induced OP is mediated through the gut-bone axis by modulating GM, repairing the intestinal barrier, and suppressing inflammatory osteoclast activation. This study provides novel evidence that the benefits of exercise on PMOP are modality-dependent, highlighting MICE as a superior strategy and offering mechanistic insights for optimizing exercise prescriptions.

运动对绝经后骨质疏松症(PMOP)的治疗至关重要,但不同运动方式的比较疗效及其潜在机制尚不清楚。本研究探讨了距离匹配高强度间歇训练(HIIT)和中等强度连续运动(MICE)对小鼠卵巢切除术(OVX)诱导的骨质疏松症(OP)的不同影响。训练12周后,显微ct分析显示,MICE(而非HIIT)显著减轻了ovx诱导的骨质流失和显微结构恶化。关键是,只有小鼠抑制破骨细胞生成,降低促炎因子(白细胞介素[IL]-6、IL-1β和肿瘤坏死因子-α [TNF-α])在股骨、血清和结肠中的表达。从机制上讲,小鼠通过上调紧密连接蛋白(TJPs、ZO-1、occludin和claudin-1)的表达,独特地恢复了肠道微生物群(GM)的多样性,减轻了生态失调,增强了肠道屏障的完整性,从而减少了全身炎症。相比之下,HIIT未能改善GM失衡和肠通透性。我们的研究结果表明,小鼠对ovx诱导的OP的保护作用是通过调节GM、修复肠道屏障和抑制炎性破骨细胞激活来介导的。这项研究提供了新的证据,证明运动对PMOP的益处是模式依赖的,强调MICE是一种优越的策略,并为优化运动处方提供了机制见解。
{"title":"Gut-Bone Axis Mediates Exercise Modality-Dependent Suppression of Inflammatory Osteoclastogenesis in Ovariectomy-Induced Bone Loss.","authors":"Yucheng Gao, Hao Wang, Liu Shi, Mumin Cao, Xiaoyu Liu, Yuanwei Zhang, Xiangxu Chen, Yijun Rong, Bowen Han, Panpan Lu, Guangchun Dai, Wenbin Fan, Yunfeng Rui, Yingjuan Li","doi":"10.1155/mi/5715332","DOIUrl":"10.1155/mi/5715332","url":null,"abstract":"<p><p>Exercise is crucial for postmenopausal osteoporosis (PMOP) management, yet the comparative efficacy of different exercise modalities and the underlying mechanisms remain unclear. This study investigated the differential effects of distance-matched high-intensity interval training (HIIT) and moderate-intensity continuous exercise (MICE) on ovariectomy (OVX)-induced osteoporosis (OP) in mice. After 12 weeks of training, micro-CT analysis revealed that MICE, but not HIIT, significantly attenuated OVX-induced bone loss and microstructural deterioration. Crucially, only MICE suppressed osteoclastogenesis and reduced proinflammatory factors (interleukin [IL]-6, IL-1β, and tumor necrosis factor-alpha [TNF-α]) expression in the femur, serum, and colon. Mechanistically, MICE uniquely restored gut microbiota (GM) diversity, mitigated dysbiosis, and enhanced intestinal barrier integrity by upregulating the expression of tight junction proteins (TJPs; ZO-1, occludin, and claudin-1), thereby reducing systemic inflammation. In contrast, HIIT failed to ameliorate GM imbalance and intestinal permeability. Our findings demonstrate that the protective effect of MICE on OVX-induced OP is mediated through the gut-bone axis by modulating GM, repairing the intestinal barrier, and suppressing inflammatory osteoclast activation. This study provides novel evidence that the benefits of exercise on PMOP are modality-dependent, highlighting MICE as a superior strategy and offering mechanistic insights for optimizing exercise prescriptions.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"5715332"},"PeriodicalIF":4.2,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mediators of Inflammation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1